Mainstream

Keros Ends Mid Stage Trial For Lead Asset After Adverse Events

Keros ends mid-stage trial for lead asset after adverse events

Keros ends mid-stage trial for lead asset after adverse events

Post ContentkrosRead More

You might also be interested in reading Bitfinex to Recommence Tokenized Bond Issuances From Alternative.

January 15, 2025
In Mainstream